Quabodepistat in combination with delamanid and bedaquiline in participants with drug-susceptible pulmonary tuberculosis: protocol for a multicenter, phase 2b/c, open-label, randomized, dose-finding trial to evaluate safety and efficacy

Peer Review reports

Original Submission
19 Oct 2023	Submitted	Original manuscript
23 Nov 2023	Reviewed	Reviewer Report - Kirsty Loudon
18 Dec 2023	Author responded	Author comments - Rodney Dawson
Resubmission - Version 2
18 Dec 2023	Submitted	Manuscript version 2
2 Jan 2024	Author responded	Author comments - Rodney Dawson
Resubmission - Version 3
2 Jan 2024	Submitted	Manuscript version 3
Publishing
3 Jan 2024	Editorially accepted
19 Jan 2024	Article published	10.1186/s13063-024-07912-5

Back to article page